Complete Regression of Hepatocellular Carcinoma with Low Dose of Sorafenib

J Clin Exp Hepatol. 2021 Nov-Dec;11(6):756-757. doi: 10.1016/j.jceh.2021.06.012. Epub 2021 Jun 17.
No abstract available